Cite
HARVARD Citation
Tanemoto, M. et al. (2022). Daily dose of alfacalcidol at conversion from intravenous maxacalcitol in secondary hyperparathyroidism management. Therapeutic apheresis and dialysis. 26 (2), pp. 471-472. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tanemoto, M. et al. (2022). Daily dose of alfacalcidol at conversion from intravenous maxacalcitol in secondary hyperparathyroidism management. Therapeutic apheresis and dialysis. 26 (2), pp. 471-472. [Online].